Pneumococcal vaccine expansion

Effective Aug. 1, provincially funded 20-valent pneumococcal conjugate vaccine (Pneu-C20 or Prevnar 20TM) eligibility has been expanded to:

• Adults 65 years of age and older, regardless of risk factors, who have never received a dose of Pneu-C20 vaccine.
• Adults 18 years of age and older who belong to one or more of the groups at increased risk for Invasive Pneumococcal Disease (IPD) will continue to be eligible for one dose of Pneu-C20, provided they have not received a prior dose.